1 Acute Intermittent Porphyria Drugs Market Overview 1.1 Product Overview and Scope of Acute Intermittent Porphyria Drugs 1.2 Acute Intermittent Porphyria Drugs Segment by Type 1.2.1 Global Acute Intermittent Porphyria Drugs Sales Growth Rate Comparison by Type (2020-2026) 1.2.2 350mg 1.2.3 313mg 1.3 Acute Intermittent Porphyria Drugs Segment by Application 1.3.1 Acute Intermittent Porphyria Drugs Sales Comparison by Application: (2020-2026) 1.3.2 Hospital 1.3.3 Pharmacy 1.4 Global Acute Intermittent Porphyria Drugs Market Size Estimates and Forecasts 1.4.1 Global Acute Intermittent Porphyria Drugs Revenue 2015-2026 1.4.2 Global Acute Intermittent Porphyria Drugs Sales 2015-2026 1.4.3 Acute Intermittent Porphyria Drugs Market Size by Region: 2020 Versus 2026 2 Global Acute Intermittent Porphyria Drugs Market Competition by Manufacturers 2.1 Global Acute Intermittent Porphyria Drugs Sales Market Share by Manufacturers (2015-2020) 2.2 Global Acute Intermittent Porphyria Drugs Revenue Share by Manufacturers (2015-2020) 2.3 Global Acute Intermittent Porphyria Drugs Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Acute Intermittent Porphyria Drugs Manufacturing Sites, Area Served, Product Type 2.5 Acute Intermittent Porphyria Drugs Market Competitive Situation and Trends 2.5.1 Acute Intermittent Porphyria Drugs Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Acute Intermittent Porphyria Drugs Players (Opinion Leaders) 3 Acute Intermittent Porphyria Drugs Retrospective Market Scenario by Region 3.1 Global Acute Intermittent Porphyria Drugs Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Acute Intermittent Porphyria Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Acute Intermittent Porphyria Drugs Market Facts & Figures by Country 3.3.1 North America Acute Intermittent Porphyria Drugs Sales by Country 3.3.2 North America Acute Intermittent Porphyria Drugs Sales by Country 3.3.3 the United States 3.3.4 Canada 3.4 Europe Acute Intermittent Porphyria Drugs Market Facts & Figures by Country 3.4.1 Europe Acute Intermittent Porphyria Drugs Sales by Country 3.4.2 Europe Acute Intermittent Porphyria Drugs Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 UK 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Acute Intermittent Porphyria Drugs Market Facts & Figures by Region 3.5.1 Asia Pacific Acute Intermittent Porphyria Drugs Sales by Region 3.5.2 Asia Pacific Acute Intermittent Porphyria Drugs Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Acute Intermittent Porphyria Drugs Market Facts & Figures by Country 3.6.1 Latin America Acute Intermittent Porphyria Drugs Sales by Country 3.6.2 Latin America Acute Intermittent Porphyria Drugs Sales by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Acute Intermittent Porphyria Drugs Market Facts & Figures by Country 3.7.1 Middle East and Africa Acute Intermittent Porphyria Drugs Sales by Country 3.7.2 Middle East and Africa Acute Intermittent Porphyria Drugs Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Acute Intermittent Porphyria Drugs Historic Market Analysis by Type 4.1 Global Acute Intermittent Porphyria Drugs Sales Market Share by Type (2015-2020) 4.2 Global Acute Intermittent Porphyria Drugs Revenue Market Share by Type (2015-2020) 4.3 Global Acute Intermittent Porphyria Drugs Price Market Share by Type (2015-2020) 4.4 Global Acute Intermittent Porphyria Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Acute Intermittent Porphyria Drugs Historic Market Analysis by Application 5.1 Global Acute Intermittent Porphyria Drugs Sales Market Share by Application (2015-2020) 5.2 Global Acute Intermittent Porphyria Drugs Revenue Market Share by Application (2015-2020) 5.3 Global Acute Intermittent Porphyria Drugs Price by Application (2015-2020) 6 Company Profiles and Key Figures in Acute Intermittent Porphyria Drugs Business 6.1 Abbott 6.1.1 Corporation Information 6.1.2 Abbott Description, Business Overview 6.1.3 Abbott Acute Intermittent Porphyria Drugs Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Abbott Products Offered 6.1.5 Abbott Recent Development 7 Acute Intermittent Porphyria Drugs Manufacturing Cost Analysis 7.1 Acute Intermittent Porphyria Drugs Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Acute Intermittent Porphyria Drugs 7.4 Acute Intermittent Porphyria Drugs Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Acute Intermittent Porphyria Drugs Distributors List 8.3 Acute Intermittent Porphyria Drugs Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Acute Intermittent Porphyria Drugs Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Acute Intermittent Porphyria Drugs by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Acute Intermittent Porphyria Drugs by Type (2021-2026) 10.2 Acute Intermittent Porphyria Drugs Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Acute Intermittent Porphyria Drugs by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Acute Intermittent Porphyria Drugs by Application (2021-2026) 10.3 Acute Intermittent Porphyria Drugs Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Acute Intermittent Porphyria Drugs by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Acute Intermittent Porphyria Drugs by Region (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Acute Intermittent Porphyria Drugs Sales (K Units) Growth Rate Comparison by Type (2015-2026) Table 2. Global Acute Intermittent Porphyria Drugs Sales (K Units) Comparison by Application: 2020 VS 2026 Table 3. Global Acute Intermittent Porphyria Drugs Market Size by Type (K Units) (US$ Million) (2020 VS 2026) Table 4. Global Key Acute Intermittent Porphyria Drugs Manufacturers Covered in This Study Table 5. Global Acute Intermittent Porphyria Drugs Sales (K Units) by Manufacturers (2015-2020) Table 6. Global Acute Intermittent Porphyria Drugs Sales Share by Manufacturers (2015-2020) Table 7. Global Acute Intermittent Porphyria Drugs Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Acute Intermittent Porphyria Drugs Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Acute Intermittent Porphyria Drugs Average Price (USD/Unit) of Key Manufacturers (2015-2020) Table 10. Manufacturers Acute Intermittent Porphyria Drugs Sales Sites and Area Served Table 11. Manufacturers Acute Intermittent Porphyria Drugs Product Types Table 12. Global Acute Intermittent Porphyria Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Acute Intermittent Porphyria Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Intermittent Porphyria Drugs as of 2019) Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Acute Intermittent Porphyria Drugs Players Table 16. Global Acute Intermittent Porphyria Drugs Sales (K Units) by Region (2015-2020) Table 17. Global Acute Intermittent Porphyria Drugs Sales Market Share by Region (2015-2020) Table 18. Global Acute Intermittent Porphyria Drugs Revenue (Million US$) by Region (2015-2020) Table 19. Global Acute Intermittent Porphyria Drugs Revenue Market Share by Region (2015-2020) Table 20. North America Acute Intermittent Porphyria Drugs Sales by Country (2015-2020) (K Units) Table 21. North America Acute Intermittent Porphyria Drugs Sales Market Share by Country (2015-2020) Table 22. North America Acute Intermittent Porphyria Drugs Revenue by Country (2015-2020) (US$ Million) Table 23. North America Acute Intermittent Porphyria Drugs Revenue Market Share by Country (2015-2020) Table 24. Europe Acute Intermittent Porphyria Drugs Sales by Country (2015-2020) (K Units) Table 25. Europe Acute Intermittent Porphyria Drugs Sales Market Share by Country (2015-2020) Table 26. Europe Acute Intermittent Porphyria Drugs Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Acute Intermittent Porphyria Drugs Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Acute Intermittent Porphyria Drugs Sales by Region (2015-2020) (K Units) Table 29. Asia Pacific Acute Intermittent Porphyria Drugs Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Acute Intermittent Porphyria Drugs Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Acute Intermittent Porphyria Drugs Revenue Market Share by Region (2015-2020) Table 32. Latin America Acute Intermittent Porphyria Drugs Sales by Country (2015-2020) (K Units) Table 33. Latin America Acute Intermittent Porphyria Drugs Sales Market Share by Country (2015-2020) Table 34. Latin America Acute Intermittent Porphyria Drugs Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Acute Intermittent Porphyria Drugs Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Acute Intermittent Porphyria Drugs Sales by Country (2015-2020) (K Units) Table 37. Middle East and Africa Acute Intermittent Porphyria Drugs Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Acute Intermittent Porphyria Drugs Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Acute Intermittent Porphyria Drugs Revenue Market Share by Country (2015-2020) Table 40. Global Acute Intermittent Porphyria Drugs Sales (K Units) by Type (2015-2020) Table 41. Global Acute Intermittent Porphyria Drugs Sales Share by Type (2015-2020) Table 42. Global Acute Intermittent Porphyria Drugs Revenue (Million US$) by Type (2015-2020) Table 43. Global Acute Intermittent Porphyria Drugs Revenue Share by Type (2015-2020) Table 44. Global Acute Intermittent Porphyria Drugs Price (USD/Unit) by Type (2015-2020) Table 45. Global Acute Intermittent Porphyria Drugs Sales (K Units) by Application (2015-2020) Table 46. Global Acute Intermittent Porphyria Drugs Sales Market Share by Application (2015-2020) Table 47. Global Acute Intermittent Porphyria Drugs Sales Growth Rate by Application (2015-2020) Table 48. Abbott Corporation Information Table 49. Abbott Description and Business Overview Table 50. Abbott Acute Intermittent Porphyria Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 51. Abbott Main Product Table 52. Abbott Recent Development Table 53. Production Base and Market Concentration Rate of Raw Material Table 54. Key Suppliers of Raw Materials Table 55. Acute Intermittent Porphyria Drugs Distributors List Table 56. Acute Intermittent Porphyria Drugs Customers List Table 57. Acute Intermittent Porphyria Drugs Market Trends Table 58. Acute Intermittent Porphyria Drugs Opportunities and Drivers Table 59. Acute Intermittent Porphyria Drugs Market Challenges Table 60. Global Acute Intermittent Porphyria Drugs Sales (K Units) Forecast by Type (2021-2026) Table 61. Global Acute Intermittent Porphyria Drugs Sales Market Share Forecast by Type (2021-2026) Table 62. Global Acute Intermittent Porphyria Drugs Revenue (Million US$) Forecast by Type (2021-2026) Table 63. Global Acute Intermittent Porphyria Drugs Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 64. Global Acute Intermittent Porphyria Drugs Sales (K Units) Forecast by Application (2021-2026) Table 65. Global Acute Intermittent Porphyria Drugs Revenue (Million US$) Forecast by Application (2021-2026) Table 66. Global Acute Intermittent Porphyria Drugs Sales (K Units) Forecast by Region (2021-2026) Table 67. Global Acute Intermittent Porphyria Drugs Sales Market Share Forecast by Region (2021-2026) Table 68. Global Acute Intermittent Porphyria Drugs Revenue Forecast by Region (2021-2026) (US$ Million) Table 69. Global Acute Intermittent Porphyria Drugs Revenue Market Share Forecast by Region (2021-2026) Table 70. Research Programs/Design for This Report Table 71. Key Data Information from Secondary Sources Table 72. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Acute Intermittent Porphyria Drugs Figure 2. Global Acute Intermittent Porphyria Drugs Sales Market Share by Type: 2020 VS 2026 Figure 3. 350mg Product Picture Figure 4. 313mg Product Picture Figure 5. Global Acute Intermittent Porphyria Drugs Consumption Market Share by Application: 2020 VS 2026 Figure 6. Hospital Figure 7. Pharmacy Figure 8. Global Acute Intermittent Porphyria Drugs Market Size 2015-2026 (US$ Million) Figure 9. Global Acute Intermittent Porphyria Drugs Sales Capacity (K Units) (2015-2026) Figure 10. Global Acute Intermittent Porphyria Drugs Market Size Market Share by Region: 2020 Versus 2026 Figure 11. Acute Intermittent Porphyria Drugs Sales Share by Manufacturers in 2020 Figure 12. Global Acute Intermittent Porphyria Drugs Revenue Share by Manufacturers in 2019 Figure 13. The Global 5 and 10 Largest Players: Market Share by Acute Intermittent Porphyria Drugs Revenue in 2019 Figure 14. Acute Intermittent Porphyria Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 15. Global Acute Intermittent Porphyria Drugs Sales Market Share by Region (2015-2020) Figure 16. Global Acute Intermittent Porphyria Drugs Sales Market Share by Region in 2019 Figure 17. Global Acute Intermittent Porphyria Drugs Revenue Market Share by Region (2015-2020) Figure 18. Global Acute Intermittent Porphyria Drugs Revenue Market Share by Region in 2019 Figure 19. North America Acute Intermittent Porphyria Drugs Sales Market Share by Country in 2019 Figure 20. North America Acute Intermittent Porphyria Drugs Revenue Market Share by Country in 2019 Figure 21. the United States Acute Intermittent Porphyria Drugs Sales Growth Rate (2015-2020) (K Units) Figure 22. the United States Acute Intermittent Porphyria Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 23. Canada Acute Intermittent Porphyria Drugs Sales Growth Rate (2015-2020) (K Units) Figure 24. Canada Acute Intermittent Porphyria Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 25. Europe Acute Intermittent Porphyria Drugs Sales Market Share by Country in 2019 Figure 26. Europe Acute Intermittent Porphyria Drugs Revenue Market Share by Country in 2019 Figure 27. Germany Acute Intermittent Porphyria Drugs Sales Growth Rate (2015-2020) (K Units) Figure 28. Germany Acute Intermittent Porphyria Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 29. France Acute Intermittent Porphyria Drugs Sales Growth Rate (2015-2020) (K Units) Figure 30. France Acute Intermittent Porphyria Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 31. UK Acute Intermittent Porphyria Drugs Sales Growth Rate (2015-2020) (K Units) Figure 32. UK Acute Intermittent Porphyria Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. Italy Acute Intermittent Porphyria Drugs Sales Growth Rate (2015-2020) (K Units) Figure 34. Italy Acute Intermittent Porphyria Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. Russia Acute Intermittent Porphyria Drugs Sales Growth Rate (2015-2020) (K Units) Figure 36. Russia Acute Intermittent Porphyria Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Asia Pacific Acute Intermittent Porphyria Drugs Sales Market Share by Region in 2019 Figure 38. Asia Pacific Acute Intermittent Porphyria Drugs Revenue Market Share by Region in 2019 Figure 39. China Acute Intermittent Porphyria Drugs Sales Growth Rate (2015-2020) (K Units) Figure 40. China Acute Intermittent Porphyria Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 41. Japan Acute Intermittent Porphyria Drugs Sales Growth Rate (2015-2020) (K Units) Figure 42. Japan Acute Intermittent Porphyria Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. South Korea Acute Intermittent Porphyria Drugs Sales Growth Rate (2015-2020) (K Units) Figure 44. South Korea Acute Intermittent Porphyria Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. India Acute Intermittent Porphyria Drugs Sales Growth Rate (2015-2020) (K Units) Figure 46. India Acute Intermittent Porphyria Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. Australia Acute Intermittent Porphyria Drugs Sales Growth Rate (2015-2020) (K Units) Figure 48. Australia Acute Intermittent Porphyria Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Taiwan Acute Intermittent Porphyria Drugs Sales Growth Rate (2015-2020) (K Units) Figure 50. Taiwan Acute Intermittent Porphyria Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Indonesia Acute Intermittent Porphyria Drugs Sales Growth Rate (2015-2020) (K Units) Figure 52. Indonesia Acute Intermittent Porphyria Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Thailand Acute Intermittent Porphyria Drugs Sales Growth Rate (2015-2020) (K Units) Figure 54. Thailand Acute Intermittent Porphyria Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Malaysia Acute Intermittent Porphyria Drugs Sales Growth Rate (2015-2020) (K Units) Figure 56. Malaysia Acute Intermittent Porphyria Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Philippines Acute Intermittent Porphyria Drugs Sales Growth Rate (2015-2020) (K Units) Figure 58. Philippines Acute Intermittent Porphyria Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Vietnam Acute Intermittent Porphyria Drugs Sales Growth Rate (2015-2020) (K Units) Figure 60. Vietnam Acute Intermittent Porphyria Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Latin America Acute Intermittent Porphyria Drugs Sales Market Share by Country in 2019 Figure 62. Latin America Acute Intermittent Porphyria Drugs Revenue Market Share by Country in 2019 Figure 63. Mexico Acute Intermittent Porphyria Drugs Sales Growth Rate (2015-2020) (K Units) Figure 64. Mexico Acute Intermittent Porphyria Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Brazil Acute Intermittent Porphyria Drugs Sales Growth Rate (2015-2020) (K Units) Figure 66. Brazil Acute Intermittent Porphyria Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Argentina Acute Intermittent Porphyria Drugs Sales Growth Rate (2015-2020) (K Units) Figure 68. Argentina Acute Intermittent Porphyria Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Middle East and Africa Acute Intermittent Porphyria Drugs Sales Market Share by Country in 2019 Figure 70. Middle East and Africa Acute Intermittent Porphyria Drugs Revenue Market Share by Country in 2019 Figure 71. Turkey Acute Intermittent Porphyria Drugs Sales Growth Rate (2015-2020) (K Units) Figure 72. Turkey Acute Intermittent Porphyria Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Saudi Arabia Acute Intermittent Porphyria Drugs Sales Growth Rate (2015-2020) (K Units) Figure 74. Saudi Arabia Acute Intermittent Porphyria Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. UAE Acute Intermittent Porphyria Drugs Sales Growth Rate (2015-2020) (K Units) Figure 76. UAE Acute Intermittent Porphyria Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Sales Market Share of Acute Intermittent Porphyria Drugs by Type (2015-2020) Figure 78. Sales Market Share of Acute Intermittent Porphyria Drugs by Type in 2020 Figure 79. Global Acute Intermittent Porphyria Drugs Market Share by Price Range (2015-2020) Figure 80. Revenue Market Share of Acute Intermittent Porphyria Drugs by Type in 2019 Figure 81. Global Acute Intermittent Porphyria Drugs Sales Growth by Type (2015-2020) (K Units) Figure 82. Sales Market Share of Acute Intermittent Porphyria Drugs by Application (2015-2020) Figure 83. Sales Market Share of Acute Intermittent Porphyria Drugs by Application in 2020 Figure 84. Revenue Share of Acute Intermittent Porphyria Drugs by Application (2015-2020) Figure 85. Revenue Share of Acute Intermittent Porphyria Drugs by Application in 2020 Figure 86. Key Raw Materials Price Trend Figure 87. Manufacturing Cost Structure of Acute Intermittent Porphyria Drugs Figure 88. Manufacturing Process Analysis of Acute Intermittent Porphyria Drugs Figure 89. Acute Intermittent Porphyria Drugs Industrial Chain Analysis Figure 90. Channels of Distribution Figure 91. Distributors Profiles Figure 92. Porter's Five Forces Analysis Figure 93. Bottom-up and Top-down Approaches for This Report Figure 94. Data Triangulation Figure 95. Key Executives Interviewed

Abbott